*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Levetiracetam acid</strong> (CAS: 151692-87-0) is the active pharmaceutical intermediate for the antiepileptic drug Levetiracetam. It is synthesized via chiral catalytic hydrogenation or enzymatic resolution processes. The molecular formula is C<sub>8</sub>H<sub>14</sub>N<sub>2</sub>O<sub>2</sub>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Primary API synthesis for epilepsy and seizure disorders.</li>
<li><strong>Research & Development:</strong> Reference standard in neuropharmacology studies.</li>
<li><strong>Quality Control:</strong> Impurity profiling in finished drug formulations.</li>
</ul>
<h3>Precautions</h3>
<p>Store in a cool, dry place below 25°C away from light. Use appropriate PPE to prevent skin contact; avoid inhalation of dust. Not intended for direct clinical administration without formulation.</p>